Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.

MLA

Sham, Jonathan G., et al. “Glypican-3-Targeting F(Ab’)2 for 89Zr PET of Hepatocellular Carcinoma.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 55, no. 12, Dec. 2014, pp. 2032–37. EBSCOhost, https://doi.org/10.2967/jnumed.114.145102.

APA

Sham, J. G., Kievit, F. M., Grierson, J. R., Chiarelli, P. A., Miyaoka, R. S., Zhang, M., Yeung, R. S., Minoshima, S., & Park, J. O. (2014). Glypican-3-targeting F(ab’)2 for 89Zr PET of hepatocellular carcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 55(12), 2032–2037. https://doi.org/10.2967/jnumed.114.145102

Chicago

Sham, Jonathan G, Forrest M Kievit, John R Grierson, Peter A Chiarelli, Robert S Miyaoka, Miqin Zhang, Raymond S Yeung, Satoshi Minoshima, and James O Park. 2014. “Glypican-3-Targeting F(Ab’)2 for 89Zr PET of Hepatocellular Carcinoma.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 55 (12): 2032–37. doi:10.2967/jnumed.114.145102.